N/A N=13 Basic Science

Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS

Acute Lung Injury (ALI) · ARDS

Bottom Line

View on ClinicalTrials.gov: NCT01272882 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2013

Primary outcome: Primary: Feasibility of EIT Monitoring in This Population of ARDS/ALI Patients — 13 Patients successfully monitored with EIT

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Electrical Impedance Tomography monitoring (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Christiana Care Health Services
Primary completion: Mar 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility of EIT Monitoring in This Population of ARDS/ALI Patients	13	—

Summary

Electrical impedance tomography (EIT) monitoring has been researched as a method to determine the spatial impedance distribution in a body cross section, but has yet to become an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of both global and regional ventilation. Recently, there has been evidence that EIT monitoring has great potential to become a non-invasive bedside tool for assessment of regional lung ventilation without documented hazards. Potential applications include any adult patients in acute respiratory failure. Data collected from this research may contribute to improved patient safety outcomes. PURPOSE: The purpose of this pilot study is to examine the feasibility of using the EIT monitor in intensive care unit (ICU) setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients.

Eligibility Criteria

Inclusion Criteria

Patients will be included in this study if the following criteria have been met:

Males and females > 18 years old (non-pregnant, non-lactating females).
Partial pressure of arterial oxygen (PaO2) / Fraction of inspired oxygen (FiO2) ratio < 300 torr.
Signed informed consent has been obtained.

Exclusion Criteria

Females who are pregnant or lactating.
Patients with skin abrasions or wounds in the chest area.
Patients receiving dialysis.
Patients with pacemakers or paced EKG rhythms.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01272882). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.